Black Opal Ventures

Co-founder of Black Opal Ventures with over 20 years in venture capital at firms including Amadeus Capital Partners, Applied Ventures, and In-Q-Tel, where she invested in companies such as Twist Bioscience and Cerebras. She previously held a senior role at Arm and was an early employee at a semiconductor startup.

Co-founder of Black Opal Ventures with a career reshaping healthcare as a physician, venture capitalist, and executive. She previously served as Chief Clinical Officer at Bind (acquired by UnitedHealth Group) and held leadership roles at McKinsey and Weill Cornell.

Heather Eve Castel is a senior private markets professional at AIP Management focused on sustainability and impact strategy, investor relations, and fund product development. She brings experience across infrastructure, private equity, and venture capital, with expertise in SFDR Article 9 positioning, EU Taxonomy alignment, and impact measurement frameworks. Her background includes roles at Barclays, HSBC, and Morgan Stanley in structured fund solutions, and she holds a CFA charter, an MBA from London Business School, and a Master's in Sustainability Leadership from the University of Cambridge.

Lilly Alexander is Head of Whole Health for Government Business and a member of the Medicaid Senior Leadership Team at Elevance Health, where she oversees integrated care innovation across 12 million members in 25 states. She previously worked in institutional equity research and private market investing, focusing on high-growth technology companies. Her background combines investment analysis with digital health strategy and enterprise healthcare transformation.

Seema Parmar is an independent consultant who previously worked at McKinsey and Cleveland Clinic. Her career has focused on designing and scaling solutions aimed at improving health outcomes and reducing disparities, with particular attention to equity in healthcare systems.